Tumor angiogenesis 2012.
J Oncol., 2012:857383 (2012)
MT103 inhibits tumor growth with minimal toxicity in murine model of lung carcinoma via induction of apoptosis.
Invest New Drugs., Oct;29(5):846-52 (2011)
Sorafenib induces partial response in metastatic medullary thyroid carcinoma.
Acta Oncol., 49(1):104-6 (2010)
A novel reduced immunogenicity bispecific targeted toxin simultaneously recognizing human epidermal growth factor and interleukin-4 receptors in a mouse model of metastatic breast carcinoma.
Clin. Cancer Res., Oct;15(19):6137-47 (2009)
PKC-alpha inhibitor MT477 slows tumor growth with minimal toxicity in in vivo model of non-Ras-mutated cancer via induction of apoptosis.
Invest New Drugs., Feb;29(1):33-40 (2011)
Single-institution outcome of high-dose interleukin-2 (HD IL-2) therapy for metastatic melanoma and analysis of favorable response in brain metastases.
Anticancer Res., Oct;29(10):4189-93 (2009)
Cytotoxic effect of zoledronic acid-loaded bone cement on giant cell tumor, multiple myeloma, and renal cell carcinoma cell lines.
J Bone Joint Surg Am., Jan;92(1):162-8 (2010)
Carbonic anhydrase IX expression is associated with improved outcome of high-dose interleukin-2 therapy for metastatic renal cell carcinoma.
Anticancer Res., Mar;30(3):987-92 (2010)
Small cell lung cancer in never smokers: report of two cases.
J Thorac Oncol., May;5(5):747-8 (2010)
Pericytes and vessel maturation during tumor angiogenesis and metastasis.
Am. J. Hematol., Aug;85(8):593-8 (2010)
Interleukin 2 in cancer therapy.
Curr. Med. Chem., 17(29):3297-302 (2010)
Blood outgrowth endothelial cell-based systemic delivery of antiangiogenic gene therapy for solid tumors.
Cancer Gene Ther., Dec;17(12):855-63 (2010)
Endothelial lineage cell as a vehicle for systemic delivery of cancer gene therapy.
Transl Res., Sep;156(3):136-46 (2010)
Small-cell carcinoma with an epidermal growth factor receptor mutation in a never-smoker with gefitinib-responsive adenocarcinoma of the lung.
Clin Lung Cancer., Sep;11(5):E1-4 (2010)
Treatment of melanoma-associated retinopathy.
Curr Treat Options Neurol., Jan;12(1):54-63 (2010)
Capecitabine for skin cancer prevention in solid organ transplant recipients.
Clin Transplant., 25(4):541-8 (2011)
MT477 acts in tumor cells as an AURKA inhibitor and strongly induces NRF-2 signaling.
Anticancer Res., Apr;31(4):1181-7 (2011)
Vaccine therapy for metastatic melanoma: systematic review and meta-analysis of clinical trials.
Melanoma Res., Jun;21(3):165-74 (2011)
Safety of nab-paclitaxel plus sunitinib: analysis of three cases.
Anticancer Res., 28(5B):3099-105 (2008)
Sequential therapy with sorafenib and sunitinib in renal cell carcinoma.
Cancer., Jan;115(1):61-7 (2009)